Japan will stop short of offering blanket coronavirus tests, and instead target the vulnerable and those most at risk in seeking to prevent a second wave of infections, the minister in charge of policies to combat the health crisis said.
Shanghai Junshi Biosciences has started an early-stage study in China to test a potential antibody treatment against the coronavirus in uninfected people, official paper Liberation Daily said on its online channel on Sunday. https://bit.ly/3eZhSWM
Germany and three other European Union states are forging a new alliance aimed at securing access to coronavirus vaccines, once developed, and making sure they are distributed fairly around the world, business daily Handelsblatt reported.
Healthcare and clinical diagnostics company Novacyt announced more contract wins for its ‘Primerdesign’ product aimed at testing for the presence of the coronavirus, although the company suffered a minor setback in France.
Drugmakers AstraZeneca Plc and Merck & Co Inc said on Monday their blockbluster cancer drug, Lynparza, has received positive recommendation from the European Medicines Agency (EMA) as a maintenance treatment for a form of pancreatic cancer.